Advances in the field of molecular biology have had an impact on biomedical applications,
which provide greater hope for both imaging and therapeutics. Work has been intensified on …

Nuclear medicine is experiencing a renaissance, with US Food and Drug Administration
approval recently being obtained for theranostic agents and a wide variety of such agents …

Purpose: In this study, DOTA-IBA was radiolabeled with 68Ga and we determined the
optimum labelling conditions and assessed the biological properties of 68Ga-DOTA-IBA. We …

Abstract Technetium-99m (99m Tc) is a radiometal that has nearly ideal nuclear properties
for diagnostic nuclear medicine imaging, which has helped make it high impact and …

Nuclear medical imaging devices, such as those enabling photon emission imaging
(gamma camera, single photon emission computed tomography, or positron emission …

Advances in the field of molecular biology have had an impact on biomedical applications,
which provide greater hope for both imaging and therapeutics. Work has been intensified on …

The pharmaceutical development of innovative radiopharmaceuticals (RPs) based on
bispecific high-affinity hypervariable fragments of single-domain monoclonal antibodies …

Radiopharmaceutical therapy directly targets radioactive drugs to cancer cells. Incorporating
radiopharmaceutical therapy requires quantitative assessment of the radiation dose …

Nuclear medicine plays a role in oncology. It uses tracers (radiopharmaceuticals) to study
physiological processes and treat diseases. The radiopharmaceuticals can be formed as …

The chemical effects of radioactive decay arise from (1) transmutation,(2) formation of
charged daughter nuclei,(3) recoil of the daughter nuclei,(4) electron “shakeoff” …